Clinical trial
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
NCT05094089 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 24, 2023
- Completion date
- July 31, 2030
- Enrollment
- 320 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
hernia incisional, hernia incisional ventral, hernia, ventral